Pharmacologically active compounds in the environment and their chirality

被引:375
|
作者
Kasprzyk-Hordern, Barbara [1 ,2 ]
机构
[1] Univ Huddersfield, Dept Chem & Biol Sci, Sch Appl Sci, Huddersfield HD1 3DH, W Yorkshire, England
[2] Univ Bath, Dept Chem, Fac Sci, Bath BA2 7AY, Avon, England
关键词
SOLID-PHASE EXTRACTION; PERSONAL CARE PRODUCTS; TANDEM MASS-SPECTROMETRY; WASTE-WATER TREATMENT; SEWAGE-TREATMENT PLANTS; ENDOCRINE-DISRUPTING COMPOUNDS; SEROTONIN REUPTAKE INHIBITORS; DIFFERENT THERAPEUTIC CLASSES; LIQUID-CHROMATOGRAPHY; ILLICIT DRUGS;
D O I
10.1039/c000408c
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Pharmacologically active compounds including both legally used pharmaceuticals and illicit drugs are potent environmental contaminants. Extensive research has been undertaken over the recent years to understand their environmental fate and toxicity. The one very important phenomenon that has been overlooked by environmental researchers studying the fate of pharmacologically active compounds in the environment is their chirality. Chiral drugs can exist in the form of enantiomers, which have similar physicochemical properties but differ in their biological properties such as distribution, metabolism and excretion, as these processes (due to stereospecific interactions of enantiomers with biological systems) usually favour one enantiomer over the other. Additionally, due to different pharmacological activity, enantiomers of chiral drugs can differ in toxicity. Furthermore, degradation of chiral drugs during wastewater treatment and in the environment can be stereoselective and can lead to chiral products of varied toxicity. The distribution of different enantiomers of the same chiral drug in the aquatic environment and biota can also be stereoselective. Biological processes can lead to stereoselective enrichment or depletion of the enantiomeric composition of chiral drugs. As a result the very same drug might reveal different activity and toxicity and this will depend on its origin and exposure to several factors governing its fate in the environment. In this critical review a discussion of the importance of chirality of pharmacologically active compounds in the environmental context is undertaken and suggestions for directions in further research are made. Several groups of chiral drugs of major environmental relevance are discussed and their pharmacological action and disposition in the body is also outlined as it is a key factor in developing a full understanding of their environmental occurrence, fate and toxicity. This review will be of interest to environmental scientists, especially those interested in issues associated with environmental contamination with pharmacologically active compounds and chiral pollutants. As the review will outline current state of knowledge on chiral drugs, it will be of value to anyone interested in the phenomenon of chirality, chiral drugs, their stereoselective disposition in the body and environmental fate (212 references).
引用
收藏
页码:4466 / 4503
页数:38
相关论文
共 50 条
  • [31] A method for rapid screening of interactions of pharmacologically active compounds with albumin
    Majcher, Aldona
    Lewandrowska, Anna
    Herold, Franciszek
    Stefanowicz, Jacek
    Slowinski, Tomasz
    Mazurek, Aleksander P.
    Wieczorek, Stefan A.
    Holyst, Robert
    ANALYTICA CHIMICA ACTA, 2015, 855 : 51 - 59
  • [32] Isolation and identification of pharmacologically active compounds in fruit of Pyrus pashia
    Chandra, Subhash
    Saklani, Sarla
    Agrawal, Rohit K.
    INTERNATIONAL JOURNAL OF MEDICAL RESEARCH & HEALTH SCIENCES, 2016, 5 (08): : 30 - 34
  • [33] Prospects of Using Pharmacologically Active Compounds for the Creation of Antimycobacterial Drugs
    Khrapova, A., V
    Saroyants, L., V
    Yushin, M. Yu
    Zukhairaeva, A. S.
    Velikorodov, A. V.
    PHARMACEUTICAL CHEMISTRY JOURNAL, 2022, 55 (10) : 1108 - 1114
  • [34] Pharmacologically active compounds from alkoxy-beta-phenylethylamines
    Ide, WS
    Buck, JS
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1937, 59 : 726 - 731
  • [35] The Search for Pharmacologically Active Compounds Among the 2-Dialkylaminobenzimidazoles
    O. N. Zhukovskaya
    V. A. Anisimova
    A. A. Spasov
    D. S. Yakovlev
    N. A. Gurova
    A. F. Kucheryavenko
    O. A. Salaznikova
    V. A. Kuznetsova
    D. V. Mal’tsev
    A. A. Brigadirova
    Ya. V. Morkovina
    O. A. Solov’eva
    V. V. Gurova
    E. V. Reznikov
    Pharmaceutical Chemistry Journal, 2017, 51 : 182 - 186
  • [36] A Computational Method for Unveiling the Target Promiscuity of Pharmacologically Active Compounds
    Schneider, Petra
    Schneider, Gisbert
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2017, 56 (38) : 11520 - 11524
  • [37] Pharmacologically active compounds from latex-bearing plants
    Warowicka, Alicja
    Nawrot, Robert
    Gozdzicka-Jozefiak, Anna
    LATEX, LATICIFERS AND THEIR MOLECULAR COMPONENTS: FROM FUNCTIONS TO POSSIBLE APPLICATIONS, 2020, 93 : 119 - 151
  • [38] Enantiomeric Profiling of Chiral Pharmacologically Active Compounds in the Environment with the Usage of Chiral Liquid Chromatography Coupled with Tandem Mass Spectrometry
    Camacho-Munoz, Dolores
    Petrie, Bruce
    Castrignano, Erika
    Kasprzyk-Hordern, Barbara
    CURRENT ANALYTICAL CHEMISTRY, 2016, 12 (04) : 303 - 314
  • [39] SITE OF ACTION OF PHARMACOLOGICALLY ACTIVE COMPOUNDS ON HEART OF PERIPLANETA AMERICANA L
    MILLER, T
    METCALF, RL
    JOURNAL OF INSECT PHYSIOLOGY, 1968, 14 (03) : 383 - &
  • [40] ELECTROPHILIC FLUORINATION OF PHARMACOLOGICALLY ACTIVE 1,3-DICARBONYL COMPOUNDS
    RESNATI, G
    DESMARTEAU, DD
    JOURNAL OF ORGANIC CHEMISTRY, 1992, 57 (15): : 4281 - 4284